ArticleAmerican journal of translational research2021
The timing of targeted therapy initiation in metastatic sarcoma as an adjuvant to first-line chemotherapy or a second-line agent.
Yujing Huang et al.PubMed ↗Full text ↗
No numbers read from the abstract.